Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-012480

Cascadian Therapeutics, Inc. · CASC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 20, 2018
Accepted (ET)
Feb 22, 2018 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412067

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 20, 2018C1,818,000$3.30A10,882,574ISee Note 1

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series E Preferred StockF1,F2$3.30Feb 20, 2018C1,818,000D——Common Stock1,818,0000I

Explanation of responses